<code id='67B774EB64'></code><style id='67B774EB64'></style>
    • <acronym id='67B774EB64'></acronym>
      <center id='67B774EB64'><center id='67B774EB64'><tfoot id='67B774EB64'></tfoot></center><abbr id='67B774EB64'><dir id='67B774EB64'><tfoot id='67B774EB64'></tfoot><noframes id='67B774EB64'>

    • <optgroup id='67B774EB64'><strike id='67B774EB64'><sup id='67B774EB64'></sup></strike><code id='67B774EB64'></code></optgroup>
        1. <b id='67B774EB64'><label id='67B774EB64'><select id='67B774EB64'><dt id='67B774EB64'><span id='67B774EB64'></span></dt></select></label></b><u id='67B774EB64'></u>
          <i id='67B774EB64'><strike id='67B774EB64'><tt id='67B774EB64'><pre id='67B774EB64'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:6
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Pfizer's RSV vaccine recommended for approval in Europe
          Pfizer's RSV vaccine recommended for approval in Europe

          PauloAmorim/VWPicsviaAPImagesLONDON—EuropeanregulatorsonFridayrecommendedtheapprovalofPfizer’sRSVvac

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Designating disabled people as health disparity population is crucial

          AdobeMydaughterKatiewasbornwithseveredisabilities.Shewentontodevelopprofoundautism,attentiondeficitd